News
We present a case of a woman in her 50s with relapsing-remitting multiple sclerosis, treated with diroximel fumarate ... investigation results, drawing original diagrams and algorithms and critical ...
The Global Multiple Sclerosis Drugs Market achieved a valuation of $23.2 Billion in 2024 and is anticipated to exceed $53.25 Billion by 2035, reflecting a compounded annual growth rate (CAGR) of 7.85% ...
2h
Travel + Leisure on MSNI've Had Multiple Sclerosis for 25+ Years and I Still Travel the World—Here's What It's LikeLifelong traveler and adventurer Robin Cohen was diagnosed with the neurological disease more than two decades ago, but she ...
By studying the effects of the nasal anti-CD3 in a ... Multiple Sclerosis: Cell-Catching Implant Helps Identify Successful Treatment in Mice Feb. 18, 2025 — A sponge-like implant in mice helped ...
Columnist Desiree Lama shares what she wishes she'd been told after her diagnosis of multiple sclerosis at age 17.
9d
MedPage Today on MSNScreening for Depression and Anxiety in Multiple SclerosisTo build a model that used routine clinical information to screen for anxiety and depression, Patten's group studied 828 MS patients at five centers who were part of the Canadian Prospective Cohort ...
Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called disability accrual. Current disease-modifying therapies for multiple ...
1d
ScienceAlert on MSNScientists Identify Specific Bacteria Linked to Multiple SclerosisHaving higher numbers of particular gut microbes might put you at a higher risk of developing multiple sclerosis (MS), a new ...
An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with their disorder, a new clinical trial suggests. The drug, tolebrutinib ...
SAVANNAH, Ga. (WTOC) - March is Multiple Sclerosis awareness month. It’s an autoimmune disease that impacts nearly a million people around the world. This month, our Jasmine Butler is bringing us ...
Get Instant Summarized Text (Gist) New therapeutic targets for multiple sclerosis (MS) tissue recovery have been identified, potentially leading to treatments that promote myelin repair. Current ...
In recently published research in the journal Neurology, the team tracked records for 4,593 people living with multiple sclerosis from 2019 to 2020, 673 in rural areas and 3,920 in urban centers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results